Skip to content

Human Muscle Gene Expression Profiles in Young and Old Men

Human Muscle Gene Expression Profiles in Young and Old Men

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00725166
Acronym
CERA
Enrollment
41
Registered
2008-07-30
Start date
2008-10-31
Completion date
2009-03-31
Last updated
2009-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly, Sarcopenia

Keywords

Aging, Biopsy, Skeletal muscle, Molecular biology, Genetic markers, Gene expression regulation, Young and old men, Healthy volunteers

Brief summary

To reach the goals of living longer in better medical conditions, many countries reach the same conclusion: new strategies have to be developed to avoid, or at least limit, the effects of age; this requires a better knowledge of the mechanisms of aging. Our project focuses on the loss of muscle mass associated with aging, called sarcopenia. Sarcopenia unavoidably leads to impaired mobility and poor balance, which contributes to loss of functional autonomy and to increased prevalence for severe falls. Skeletal muscle also plays a central role as a reserve for energy and amino acids. Hence, sarcopenia further triggers severe side metabolic effects such as frailty among elderly persons. The precise mechanisms of muscle aging are still mostly unknown, although many theories have been proposed. The present study aims at better understanding the mechanisms of skeletal muscle loss associated with aging. Using muscle biopsies from young and old subjects, the differential expression profiles of mRNA will be obtained through chips that will evaluate more than 39000 transcripts. On the same samples, proteomic analyses will involve two complementary approaches: (1) bidimensional electrophoresis (2DGE) coupled to mass spectrometry (MALDI-ToF) for dominant proteins; (2) Western-blot (more than 800 antibodies) targeting regulating proteins not detectable using 2DGE. Complementary histological studies (immunohisto-fluorescence, confocal microscopy) will specify the localisation of the major biomarkers in the muscle biopsies. The results of that research will have applications in the medium term and will lead to nutritional interventions to modulate specific metabolic pathways and improve the quality of life in the elderly.

Interventions

OTHERSkeletal muscle aging

W1 - Blood test * Maximal voluntary contraction of quadriceps * Hydrostatic weighing W2 - Maximal metabolic test using a cycloergometer W3 - Muscular biopsy

Sponsors

Fondation des Caisses d'Epargne Rhône-Alpes
CollaboratorUNKNOWN
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
CollaboratorOTHER
Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
19 Years to 76 Years
Healthy volunteers
Yes

Inclusion criteria

* Affiliated or beneficiary of a social security category * Having signed the inform consent form * Having signed the genetic consent form

Exclusion criteria

* Antiaggregant platelet treatment * Type 2 diabetes * Body Mass Index \> 25 * Severe renal disease * CRP \> 10 * Abnormal clotting test * Allergies to local anesthetics

Design outcomes

Primary

MeasureTime frame
To identify the differential expression profiles (proteomics, transcriptomics) in skeletal muscle between young and old menDuring biopsie (W3)

Secondary

MeasureTime frame
To specify the localisation of the major biomarkers in the muscle biopsies.During biopsie (W3)
To compare muscular energy metabolic enzymatic activities between young and old menduring biopsie (W3)
To compare the number of muscular stem cells between young and old menduring biopsie (W3)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026